We serve Chemical Name:Methotrexate CAS:59-05-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methotrexate
CAS.NO:59-05-2
Synonyms:R 9985;MFCD00064370;EINECS 200-413-8;Amethopterine;N-(4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)-L-glutamic acid;L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-;N-(4-{[(2,4-Diamino-6-pteridinyl)methyl](methyl)amino}benzoyl)-L-glutamic acid;(2S)-2-{[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]amino}pentanedioic acid;X 133;L-Amethopterin;L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-;TCMDC-125858;MTX;Hdmtx;α-Methopterin;L-A-methopterin;(+)-Amethopterin;4-Amino-N10-methylfolic Acid;4-amino-4-deoxy-10-methylpteroyl-L-glutamic acid;Methotrexate;L-(+)-N-[p-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]glutamic Acid;L-Methotrexate;Mexate;4-Amino-N10-methylpteroylglutamic Acid
Molecular Formula:C20H22N8O5
Molecular Weight:454.439
HS Code:2933990090
Physical and Chemical Properties:
Melting point:195°C
Boiling point:N/A
Density:1.5±0.1 g/cm3
Index of Refraction:1.738
PSA:210.54000
Exact Mass:454.171326
LogP:-0.24
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1/PG 3
Packing Group:III
Contact us for information like R 9985 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Amino-N10-methylpteroylglutamic Acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,α-Methopterin Use and application,L-Methotrexate technical grade,usp/ep/jp grade.
Related News: Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and optimize clinical trial development, today announces the appointment of Grégoire Boutonnet as Chief Operating Officer, effective immediately. 2-isopropyl-2-methyl-3-thioxo-2,3-dihydro-5H-imidazo[1′,2′:1,2]pyrrolo[3,4-b]quinolin-5-one manufacturers For skin rash, the difference in response rates for anifrolumab versus placebo at week 52 were 13.5% SLE Disease Activity Index (SLEDAI), 15.5% British Isles Lupus Assessment Group index (BILAG) and 15.6% modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). For arthritis, differences in response rates were 8.2% SLEDAI, 11.8% BILAG and 12.6% joint response. Tetrahydrozexbrevin suppliers In recent years, it has benefited significantly from the development of a broad range of enabling technologies, leading biocatalysis to become an established methodology for efficient, sustainable manufacturing, especially within the drug development industry. N-Pentyl-N’-3-chlorpropionylpiperazin*p-Toluolsulfonat vendor & factory.
